Verrica Pharmaceuticals appoints Terry Kohler as CFO, replacing Brian Davis effective July 16, 2021

Verrica Pharmaceuticals Inc.

Brian Davis terminated as CFO effective July 16, 2021; eligible for severance subject to separation agreement.
Terry Kohler appointed CFO effective July 16, 2021; previously VP of Corporate Development and Treasurer at Endo.
Kohler receives $350,000 base salary, 40% target bonus, and option to purchase 125,000 shares vesting over 4 years.
Kohler holds an MBA from UNC Chapel Hill and is a Certified Management Accountant.
Employment at-will; severance provisions vary based on timing and change in control.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brian Davis

Chief Financial Officer

VRCA · Verrica Pharmaceuticals Inc.

Effective: 2021-07-16
Successor: Terry Kohler
Filed: July 9, 2021, 7:59 PM ET

On July 6, 2021, Verrica Pharmaceuticals Inc. (the “Company”) notified Brian Davis that his employment as Chief Financial Officer of the Company would terminate, effective as of July 16, 2021.

Appointed

Terry Kohler

Chief Financial Officer

VRCA · Verrica Pharmaceuticals Inc.

Effective: 2021-07-16
Filed: July 9, 2021, 7:59 PM ET

On July 8, 2021 the board of directors (the “Board”) of the Company appointed Terry Kohler as the Company’s Chief Financial Officer, effective as of July 16, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian Davis was terminated as Chief Financial Officer at Verrica Pharmaceuticals Inc..

Action: terminated
Role: Chief Financial Officer

Exact text from the filing

On July 6, 2021, Verrica Pharmaceuticals Inc. (the “Company”) notified Brian Davis that his employment as Chief Financial Officer of the Company would terminate, effective as of July 16, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Terry Kohler was appointed as Chief Financial Officer at Verrica Pharmaceuticals Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On July 8, 2021 the board of directors (the “Board”) of the Company appointed Terry Kohler as the Company’s Chief Financial Officer, effective as of July 16, 2021.

View on SEC.gov

Verrica Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-211337

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.